文献速递介入泌尿生殖腹部

症状性术后盆腔淋巴囊肿的治疗:一项系统综述

Treatment of symptomatic postoperative pelvic lymphoceles: A systematic review.
PubMed 文献 · Eur J Radiol · 2020-12-02

该系统综述检索截至2019年9月的PubMed、EMBASE和Cochrane数据库,纳入37项研究共732个淋巴囊肿,比较经皮细针抽吸、经皮导管引流、经皮导管引流联合硬化治疗(延迟或即时添加)及栓塞治疗的疗效。经皮导管引流联合延迟硬化治疗与单纯经皮导管引流相比,汇总相对危险度为1.57(95%CI:1.17-2.10)。作者结论认为经皮导管引流联合硬化治疗的成功率优于单纯引流,延迟硬化治疗和栓塞治疗结局最佳。

要点

  • 经皮导管引流联合延迟硬化治疗与单纯经皮导管引流相比,汇总相对危险度为1.57(95%CI:1.17-2.10)。
  • 各干预成功比例:经皮细针抽吸0.341(95%CI:0.185-0.542),经皮导管引流0.612(95%CI:0.490-0.722)。
  • 经皮导管引流联合延迟或即时添加硬化治疗成功比例0.890(95%CI:0.781-0.948),栓塞治疗0.872(95%CI:0.710-0.949)及0.922(95%CI:0.731-0.981)。

核心结论

  • 系统综述显示,治疗后盆腔淋巴囊肿时经皮导管引流联合硬化治疗的成功率优于单纯经皮导管引流。
  • 经皮导管引流联合延迟添加硬化治疗和栓塞治疗显示最佳结局。

研究设计与样本

  • 系统综述,采用预设检索策略检索PubMed、EMBASE和Cochrane数据库,检索时间从建库至2019年9月。
  • 纳入37项符合条件的研究,共732个淋巴囊肿。
  • 使用非随机干预研究偏倚风险工具进行质量评价,采用I2和χ2检验评估统计异质性,对报告多种干预的研究考虑进行Meta分析。

诊断标准与关键数值

  • 经皮细针抽吸的成功干预比例为0.341(95%CI:0.185-0.542)。
  • 经皮导管引流的成功干预比例为0.612(95%CI:0.490-0.722)。
  • 经皮导管引流联合延迟或即时添加硬化治疗的成功干预比例为0.890(95%CI:0.781-0.948)。
  • 栓塞治疗的成功干预比例为0.872(95%CI:0.710-0.949)及0.922(95%CI:0.731-0.981)。
  • 7项研究的随机效应Meta分析显示,经皮导管引流联合延迟添加硬化治疗与单纯经皮导管引流相比,汇总相对危险度为1.57(95%CI:1.17-2.10)。

局限性

  • 本研究的偏倚风险为严重。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: A broad range of therapeutic options exists for symptomatic postoperative lymphoceles. However, no consensus exists on what is the optimal therapy. In this study, we aimed to compare the efficacy of currently available radiologic interventions in terms of number of successful interventions, number of recurrences, and number of complications.

METHODS: A systematic review was conducted with a pre-defined search strategy for PubMed, EMBASE, and Cochrane databases from inception until September 2019. Quality assessment was performed using the 'Risk Of Bias In Non-randomized Studies - of Interventions' tool. Statistical heterogeneity was assessed using the I2 and χ2 test and a meta-analysis was considered for studies reporting on multiple interventions.

RESULTS: 37 eligible studies including 732 lymphoceles were identified. Proportions of successful interventions for percutaneous fine needle aspiration, percutaneous catheter drainage, percutaneous catheter drainage with delayed or instantaneous addition of sclerotherapy, and embolization were as follows: 0.341 (95% confidence interval [CI]: 0.185-0.542), 0.612 (95% CI: 0.490-0.722), 0.890 (95% CI: 0.781-0.948), 0.872 (95% CI: 0.710-0.949), 0.922 (95% CI: 0.731-0.981). Random-effects meta-analysis of seven studies revealed a pooled relative risk for percutaneous catheter drainage with delayed addition of sclerotherapy of 1.57 (95% CI: 1.17-2.10) when compared to percutaneous catheter drainage alone. The risk of bias in this study was severe.

CONCLUSIONS: This systematic review demonstrates that the success rates of percutaneous catheter drainage with sclerotherapy are more favorable when compared to percutaneous catheter drainage alone in the treatment of postoperative pelvic lymphoceles. Overall, percutaneous catheter drainage with delayed addition of sclerotherapy, and embolization showed the best outcomes.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ten Hove AS, Tjiong MY, Zijlstra IAJ, et al. Treatment of symptomatic postoperative pelvic lymphoceles: A systematic review. Eur J Radiol. 2020. PMID: 33302026. doi:10.1016/j.ejrad.2020.109459

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。